11/8/26 Accelerated Pathways and Global Harmonization Previous Leveraging Natural History and RWE for Rare Approvals Next Mock Formal FDA Meeting: How to Respond When FDA Disagrees You Might Also Like Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle Practical Application of Bayesian Networks in Rare Disease Trials Who Really Decides Which Rare Disease Therapies Survive: Regulators, Investors, Payers, or Patients? Commercial Success in Rare Disease Takes an Ecosystem: Aligning Manufacturers, Specialty Pharmacy, Providers, and Patient Support
11/8/26 Accelerated Pathways and Global Harmonization Previous Leveraging Natural History and RWE for Rare Approvals Next Mock Formal FDA Meeting: How to Respond When FDA Disagrees You Might Also Like Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle Practical Application of Bayesian Networks in Rare Disease Trials Who Really Decides Which Rare Disease Therapies Survive: Regulators, Investors, Payers, or Patients? Commercial Success in Rare Disease Takes an Ecosystem: Aligning Manufacturers, Specialty Pharmacy, Providers, and Patient Support
